Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Diagnosis & Disease Information
Risk of Drug-Drug Interactions in Patients With HIV and Cancer
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.
Updates in Targeted Therapies, Management Strategies for Non-Small Cell Lung Cancer
In an oral presentation at the 2023 ONA Summit, a thoracic oncology nurse practitioner reviewed the advances in the treatment of NSCLC and management of related adverse effects.
Screening Catches Only 1 in 7 Cancers
Vast majority of cancers diagnosed due to symptoms or other medical care.
Lung Cancer Risk Increased for Smokers Not Offered Annual Screening
Risk for incident lung cancer increased for current smokers and former smokers not recommended for annual low-dose CT screening
Risk for Cardiovascular Disease Increased for Adult Cancer Survivors
Risk for CVD, heart failure, and stroke significantly increased after adjustment for cardiovascular risk factors.
Method Improves Risk Assessment for Lung Cancer Screening
The approach improved risk assessment compared with 2021 USPSTF screening criteria.
Stat Consult: Small Cell Lung Cancer
This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of small cell lung cancer.
Updated Screening Guidelines for 5 Cancer Types
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Smoking History May Predict Immune Checkpoint Inhibitor Outcomes in Metastatic Non-Small Cell Lung Cancer
A detailed smoking history may help to inform patient outcomes.
- Loading...
Loading...
Next post in Oncology Information Center
Loading... 
Loading...